Thrivent Financial for Lutherans’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-30,699
Closed -$1.2M 2567
2024
Q4
$1.2M Sell
30,699
-12,394
-29% -$486K ﹤0.01% 1793
2024
Q3
$1.7M Hold
43,093
﹤0.01% 1559
2024
Q2
$1.68M Buy
+43,093
New +$1.68M ﹤0.01% 1500